| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 45 | 2023 | 2665 | 2.920 |
Why?
|
| Magnetic Resonance Imaging | 29 | 2024 | 7895 | 1.250 |
Why?
|
| Radiology | 10 | 2011 | 426 | 1.210 |
Why?
|
| Certification | 6 | 2005 | 107 | 1.180 |
Why?
|
| Gadolinium | 3 | 2020 | 169 | 1.010 |
Why?
|
| Image Enhancement | 7 | 2019 | 553 | 1.000 |
Why?
|
| Tomography, X-Ray Computed | 32 | 2020 | 7783 | 0.970 |
Why?
|
| Contrast Media | 11 | 2024 | 1499 | 0.890 |
Why?
|
| Sarcoma | 10 | 2024 | 1839 | 0.890 |
Why?
|
| Positron-Emission Tomography | 10 | 2015 | 2197 | 0.820 |
Why?
|
| Diagnostic Imaging | 12 | 2023 | 1174 | 0.780 |
Why?
|
| Soft Tissue Neoplasms | 8 | 2020 | 927 | 0.740 |
Why?
|
| Radiography | 51 | 2023 | 1986 | 0.720 |
Why?
|
| Multimodal Imaging | 3 | 2014 | 550 | 0.720 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2019 | 9 | 0.690 |
Why?
|
| Muscle Neoplasms | 2 | 2011 | 108 | 0.650 |
Why?
|
| Specialty Boards | 4 | 2005 | 40 | 0.600 |
Why?
|
| Whole Body Imaging | 4 | 2020 | 120 | 0.580 |
Why?
|
| Fluorodeoxyglucose F18 | 7 | 2015 | 1260 | 0.520 |
Why?
|
| Education, Medical, Continuing | 4 | 2005 | 231 | 0.520 |
Why?
|
| Musculoskeletal System | 2 | 2019 | 37 | 0.470 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2020 | 880 | 0.470 |
Why?
|
| Bone Cysts | 4 | 2011 | 15 | 0.470 |
Why?
|
| Osteosarcoma | 12 | 2019 | 950 | 0.450 |
Why?
|
| Pattern Recognition, Automated | 1 | 2014 | 120 | 0.450 |
Why?
|
| Osteochondroma | 1 | 2013 | 11 | 0.430 |
Why?
|
| Computed Tomography Angiography | 4 | 2019 | 247 | 0.430 |
Why?
|
| Lipoma | 5 | 2011 | 93 | 0.420 |
Why?
|
| Spine | 6 | 2017 | 312 | 0.420 |
Why?
|
| Osteitis | 2 | 2009 | 16 | 0.380 |
Why?
|
| Liposarcoma | 4 | 2017 | 248 | 0.370 |
Why?
|
| Radiopharmaceuticals | 8 | 2020 | 1341 | 0.370 |
Why?
|
| Free Tissue Flaps | 4 | 2019 | 374 | 0.370 |
Why?
|
| Bone Diseases | 6 | 2009 | 143 | 0.360 |
Why?
|
| Humans | 141 | 2024 | 270740 | 0.360 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2020 | 10400 | 0.350 |
Why?
|
| Sacrum | 1 | 2011 | 138 | 0.350 |
Why?
|
| Clinical Competence | 4 | 2005 | 1325 | 0.330 |
Why?
|
| Hyperostosis | 1 | 2009 | 6 | 0.330 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2016 | 585 | 0.330 |
Why?
|
| Bone and Bones | 10 | 2009 | 605 | 0.300 |
Why?
|
| Bone Cysts, Aneurysmal | 3 | 2013 | 20 | 0.280 |
Why?
|
| Chondrosarcoma | 3 | 2023 | 213 | 0.280 |
Why?
|
| Retroperitoneal Neoplasms | 3 | 2017 | 296 | 0.280 |
Why?
|
| Radiography, Thoracic | 3 | 2010 | 477 | 0.280 |
Why?
|
| Chordoma | 3 | 2023 | 170 | 0.280 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 339 | 0.270 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2004 | 24 | 0.240 |
Why?
|
| Kyphosis | 1 | 2004 | 45 | 0.240 |
Why?
|
| Bone Cements | 1 | 2004 | 50 | 0.240 |
Why?
|
| Fibula | 2 | 2018 | 153 | 0.230 |
Why?
|
| Neoplasm Metastasis | 6 | 2011 | 5315 | 0.230 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1379 | 0.230 |
Why?
|
| Chondroma | 3 | 2014 | 30 | 0.230 |
Why?
|
| Diagnosis, Differential | 22 | 2019 | 4831 | 0.220 |
Why?
|
| Thigh | 3 | 2016 | 165 | 0.220 |
Why?
|
| Carcinoma | 2 | 2011 | 2610 | 0.210 |
Why?
|
| Hemipelvectomy | 1 | 2023 | 38 | 0.210 |
Why?
|
| Thyroid Nodule | 1 | 2023 | 92 | 0.210 |
Why?
|
| Middle Aged | 46 | 2024 | 90352 | 0.200 |
Why?
|
| Female | 68 | 2024 | 148940 | 0.200 |
Why?
|
| Angiography | 4 | 2012 | 350 | 0.200 |
Why?
|
| Educational Measurement | 1 | 2005 | 397 | 0.190 |
Why?
|
| Male | 61 | 2024 | 128315 | 0.190 |
Why?
|
| Pulmonary Embolism | 1 | 2004 | 342 | 0.180 |
Why?
|
| Sensitivity and Specificity | 8 | 2016 | 5162 | 0.180 |
Why?
|
| Radionuclide Imaging | 7 | 2011 | 655 | 0.180 |
Why?
|
| Bone Transplantation | 2 | 2019 | 152 | 0.180 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2020 | 33 | 0.180 |
Why?
|
| Adult | 49 | 2024 | 82040 | 0.170 |
Why?
|
| Dermatofibrosarcoma | 1 | 2020 | 73 | 0.170 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2019 | 38 | 0.170 |
Why?
|
| Knee Injuries | 2 | 2013 | 54 | 0.170 |
Why?
|
| Neuronavigation | 1 | 2019 | 47 | 0.170 |
Why?
|
| Lumbosacral Region | 1 | 2019 | 55 | 0.170 |
Why?
|
| Scapula | 1 | 2019 | 34 | 0.160 |
Why?
|
| Breast Neoplasms | 10 | 2013 | 16215 | 0.160 |
Why?
|
| Ossification, Heterotopic | 1 | 2019 | 70 | 0.160 |
Why?
|
| Giant Cell Tumor of Bone | 2 | 2017 | 53 | 0.160 |
Why?
|
| Chemotherapy-Induced Febrile Neutropenia | 1 | 2018 | 33 | 0.160 |
Why?
|
| Education, Medical, Graduate | 1 | 2005 | 705 | 0.160 |
Why?
|
| Femur | 3 | 2012 | 161 | 0.160 |
Why?
|
| Fibroma | 4 | 2008 | 86 | 0.150 |
Why?
|
| Preoperative Care | 4 | 2019 | 1567 | 0.150 |
Why?
|
| Health Care Reform | 1 | 1998 | 64 | 0.150 |
Why?
|
| Perforator Flap | 1 | 2019 | 96 | 0.150 |
Why?
|
| Asphyxia | 1 | 2017 | 20 | 0.140 |
Why?
|
| Forensic Medicine | 3 | 1988 | 18 | 0.140 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2016 | 202 | 0.140 |
Why?
|
| Glomus Tumor | 1 | 2017 | 29 | 0.140 |
Why?
|
| Lung Neoplasms | 10 | 2011 | 12033 | 0.140 |
Why?
|
| Sciatic Nerve | 1 | 2017 | 120 | 0.140 |
Why?
|
| Denosumab | 1 | 2017 | 72 | 0.140 |
Why?
|
| Biopsy | 4 | 2020 | 3484 | 0.140 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 1990 | 557 | 0.140 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2017 | 72 | 0.140 |
Why?
|
| United States | 11 | 2011 | 15861 | 0.140 |
Why?
|
| Physicians | 1 | 2005 | 854 | 0.130 |
Why?
|
| Adolescent | 23 | 2017 | 32767 | 0.130 |
Why?
|
| Femoral Neoplasms | 3 | 2013 | 66 | 0.130 |
Why?
|
| Body Water | 1 | 2016 | 124 | 0.130 |
Why?
|
| Aged | 31 | 2024 | 73333 | 0.130 |
Why?
|
| Spinal Diseases | 3 | 2011 | 131 | 0.130 |
Why?
|
| Joint Diseases | 1 | 1995 | 71 | 0.120 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2018 | 770 | 0.120 |
Why?
|
| Retrospective Studies | 19 | 2024 | 39890 | 0.120 |
Why?
|
| Neoplasm Staging | 9 | 2014 | 14012 | 0.120 |
Why?
|
| Laser Therapy | 1 | 2019 | 466 | 0.120 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2014 | 39 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 2400 | 0.120 |
Why?
|
| Reproducibility of Results | 6 | 2023 | 6177 | 0.120 |
Why?
|
| Tibia | 2 | 2013 | 125 | 0.120 |
Why?
|
| Pleural Neoplasms | 2 | 2011 | 485 | 0.110 |
Why?
|
| Eosinophilic Granuloma | 3 | 2008 | 14 | 0.110 |
Why?
|
| Tomography, Emission-Computed | 2 | 2012 | 334 | 0.110 |
Why?
|
| Ultrasonography | 6 | 2023 | 1933 | 0.110 |
Why?
|
| Breast | 2 | 2019 | 1369 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2023 | 6764 | 0.100 |
Why?
|
| Accidents, Aviation | 3 | 1988 | 7 | 0.100 |
Why?
|
| Pathology Department, Hospital | 1 | 2011 | 15 | 0.100 |
Why?
|
| Clavicle | 2 | 2008 | 68 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2014 | 4116 | 0.100 |
Why?
|
| Algorithms | 6 | 2016 | 3891 | 0.100 |
Why?
|
| Bevacizumab | 1 | 2015 | 967 | 0.100 |
Why?
|
| Military Medicine | 1 | 2011 | 54 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2016 | 715 | 0.100 |
Why?
|
| Osteochondrodysplasias | 1 | 1992 | 75 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 1998 | 855 | 0.090 |
Why?
|
| Child | 18 | 2015 | 30559 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 2011 | 96 | 0.090 |
Why?
|
| Thoracic Neoplasms | 2 | 2011 | 363 | 0.090 |
Why?
|
| Disease Progression | 5 | 2020 | 6867 | 0.090 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2011 | 110 | 0.090 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2010 | 334 | 0.090 |
Why?
|
| Arm | 1 | 2011 | 139 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2018 | 2441 | 0.090 |
Why?
|
| Periosteum | 2 | 2009 | 46 | 0.090 |
Why?
|
| Surgical Flaps | 1 | 2016 | 894 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 160 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 909 | 0.090 |
Why?
|
| Response Evaluation Criteria in Solid Tumors | 2 | 2020 | 164 | 0.090 |
Why?
|
| Tomography, Spiral Computed | 1 | 2010 | 128 | 0.090 |
Why?
|
| Wound Healing | 3 | 2012 | 749 | 0.090 |
Why?
|
| Follow-Up Studies | 7 | 2014 | 15218 | 0.090 |
Why?
|
| Necrosis | 2 | 2009 | 595 | 0.090 |
Why?
|
| Pericardium | 2 | 2003 | 146 | 0.090 |
Why?
|
| Cystadenocarcinoma | 1 | 1989 | 24 | 0.090 |
Why?
|
| Extremities | 1 | 2011 | 311 | 0.080 |
Why?
|
| Head | 1 | 2011 | 248 | 0.080 |
Why?
|
| Splenic Neoplasms | 2 | 1989 | 124 | 0.080 |
Why?
|
| Acne Vulgaris | 1 | 2009 | 42 | 0.080 |
Why?
|
| Myxoma | 1 | 1989 | 67 | 0.080 |
Why?
|
| Radiation Oncology | 2 | 2005 | 558 | 0.080 |
Why?
|
| Multiple Myeloma | 2 | 2020 | 2328 | 0.080 |
Why?
|
| Urinary Bladder Diseases | 1 | 1989 | 53 | 0.080 |
Why?
|
| Young Adult | 5 | 2014 | 22251 | 0.080 |
Why?
|
| Neck | 1 | 2011 | 395 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2011 | 360 | 0.080 |
Why?
|
| Glioma | 1 | 2019 | 1978 | 0.080 |
Why?
|
| Ribs | 1 | 2009 | 82 | 0.080 |
Why?
|
| World Health Organization | 1 | 2010 | 327 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 3 | 2017 | 5231 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 1269 | 0.080 |
Why?
|
| Intestine, Small | 3 | 1976 | 522 | 0.070 |
Why?
|
| Osteitis Deformans | 3 | 1988 | 31 | 0.070 |
Why?
|
| Foot Diseases | 1 | 1987 | 47 | 0.070 |
Why?
|
| Knee | 1 | 2007 | 31 | 0.070 |
Why?
|
| Histiocytoma, Benign Fibrous | 2 | 1990 | 74 | 0.070 |
Why?
|
| Fractures, Spontaneous | 1 | 2007 | 87 | 0.070 |
Why?
|
| Subtraction Technique | 1 | 2007 | 143 | 0.070 |
Why?
|
| Appendiceal Neoplasms | 1 | 1989 | 251 | 0.070 |
Why?
|
| Osteomyelitis | 3 | 1991 | 258 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2009 | 1824 | 0.070 |
Why?
|
| Prevalence | 2 | 2011 | 3404 | 0.070 |
Why?
|
| Radiosurgery | 1 | 2015 | 1383 | 0.070 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1989 | 442 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2011 | 2353 | 0.060 |
Why?
|
| Syndrome | 1 | 2009 | 1407 | 0.060 |
Why?
|
| Wilms Tumor | 3 | 1983 | 301 | 0.060 |
Why?
|
| Bronchial Neoplasms | 1 | 1986 | 82 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2015 | 13414 | 0.060 |
Why?
|
| Femoral Fractures | 1 | 1986 | 66 | 0.060 |
Why?
|
| Self-Evaluation Programs | 1 | 2005 | 3 | 0.060 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 30998 | 0.060 |
Why?
|
| Child, Preschool | 10 | 2009 | 17061 | 0.060 |
Why?
|
| Comorbidity | 1 | 2011 | 2394 | 0.060 |
Why?
|
| Professional Practice | 1 | 2005 | 80 | 0.060 |
Why?
|
| Health Physics | 1 | 2005 | 62 | 0.060 |
Why?
|
| Disease-Free Survival | 5 | 2017 | 10265 | 0.060 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 4958 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 1989 | 705 | 0.060 |
Why?
|
| Kidney Neoplasms | 7 | 1983 | 3108 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 4895 | 0.050 |
Why?
|
| Prognosis | 9 | 2014 | 22505 | 0.050 |
Why?
|
| Competency-Based Education | 1 | 2004 | 81 | 0.050 |
Why?
|
| Psoas Muscles | 1 | 2023 | 12 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2023 | 41 | 0.050 |
Why?
|
| Gadolinium DTPA | 2 | 2015 | 173 | 0.050 |
Why?
|
| Research Design | 1 | 2010 | 1569 | 0.050 |
Why?
|
| Sarcoma, Ewing | 1 | 2007 | 428 | 0.050 |
Why?
|
| Lung Diseases | 3 | 1978 | 755 | 0.050 |
Why?
|
| Peritoneal Neoplasms | 1 | 1989 | 859 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1987 | 496 | 0.050 |
Why?
|
| Postural Balance | 1 | 2023 | 94 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 5056 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 984 | 0.050 |
Why?
|
| Cysts | 3 | 1980 | 205 | 0.050 |
Why?
|
| Neoplasms | 2 | 2024 | 15927 | 0.050 |
Why?
|
| Benchmarking | 1 | 2024 | 275 | 0.050 |
Why?
|
| Survival Rate | 5 | 2017 | 12541 | 0.050 |
Why?
|
| Hyperostosis, Cortical, Congenital | 1 | 1981 | 3 | 0.050 |
Why?
|
| Periostitis | 1 | 1981 | 4 | 0.050 |
Why?
|
| Infant | 6 | 2009 | 13999 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2024 | 1690 | 0.050 |
Why?
|
| Smoking | 1 | 2010 | 2555 | 0.050 |
Why?
|
| Hand | 1 | 1982 | 175 | 0.050 |
Why?
|
| Lung | 5 | 1978 | 3298 | 0.040 |
Why?
|
| Fractures, Avulsion | 1 | 2019 | 5 | 0.040 |
Why?
|
| Tendinopathy | 1 | 2019 | 15 | 0.040 |
Why?
|
| Myositis Ossificans | 1 | 2019 | 17 | 0.040 |
Why?
|
| Mesothelioma | 1 | 2005 | 558 | 0.040 |
Why?
|
| Chondrocalcinosis | 1 | 2019 | 26 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 1034 | 0.040 |
Why?
|
| Radiation Injuries | 3 | 2005 | 1471 | 0.040 |
Why?
|
| Kidney Diseases, Cystic | 1 | 1979 | 56 | 0.040 |
Why?
|
| Pain | 1 | 2007 | 1694 | 0.040 |
Why?
|
| Pulmonary Emphysema | 2 | 1978 | 159 | 0.040 |
Why?
|
| Combined Modality Therapy | 4 | 2012 | 9039 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2024 | 33737 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 4372 | 0.040 |
Why?
|
| Managed Care Programs | 1 | 1998 | 83 | 0.040 |
Why?
|
| Fever | 1 | 1981 | 521 | 0.040 |
Why?
|
| Arteries | 1 | 2019 | 291 | 0.040 |
Why?
|
| Hemangioma | 5 | 1988 | 157 | 0.040 |
Why?
|
| Infant, Newborn, Diseases | 2 | 1981 | 182 | 0.040 |
Why?
|
| Curettage | 1 | 2017 | 22 | 0.040 |
Why?
|
| Kidney | 3 | 1983 | 2121 | 0.040 |
Why?
|
| Risk Factors | 2 | 2011 | 17888 | 0.040 |
Why?
|
| Calcinosis | 2 | 2019 | 426 | 0.040 |
Why?
|
| Eye Abnormalities | 1 | 1977 | 112 | 0.040 |
Why?
|
| Protein-Losing Enteropathies | 1 | 1976 | 19 | 0.030 |
Why?
|
| Gout | 1 | 2019 | 146 | 0.030 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1977 | 88 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2024 | 2250 | 0.030 |
Why?
|
| Wounds and Injuries | 2 | 2019 | 437 | 0.030 |
Why?
|
| Health Expenditures | 1 | 1998 | 202 | 0.030 |
Why?
|
| Synovial Cyst | 1 | 1995 | 7 | 0.030 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 1976 | 15 | 0.030 |
Why?
|
| Urography | 3 | 1983 | 57 | 0.030 |
Why?
|
| Pyloric Antrum | 1 | 1976 | 77 | 0.030 |
Why?
|
| Bronchography | 1 | 1975 | 24 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 1995 | 64 | 0.030 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1975 | 74 | 0.030 |
Why?
|
| Liver | 1 | 2005 | 3086 | 0.030 |
Why?
|
| Intestinal Polyps | 1 | 1975 | 79 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2012 | 2828 | 0.030 |
Why?
|
| Scleroderma, Systemic | 1 | 1976 | 165 | 0.030 |
Why?
|
| Thoracic Vertebrae | 2 | 2011 | 200 | 0.030 |
Why?
|
| Mediastinal Cyst | 1 | 1973 | 21 | 0.030 |
Why?
|
| Bronchial Diseases | 1 | 1973 | 46 | 0.030 |
Why?
|
| Mucus | 1 | 1973 | 109 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2013 | 109 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2013 | 91 | 0.030 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2013 | 106 | 0.030 |
Why?
|
| Skull | 2 | 1989 | 251 | 0.030 |
Why?
|
| Arthropathy, Neurogenic | 1 | 1992 | 5 | 0.030 |
Why?
|
| Gastritis | 1 | 1976 | 404 | 0.030 |
Why?
|
| Esophagus | 1 | 1976 | 563 | 0.030 |
Why?
|
| Societies, Medical | 1 | 1998 | 1320 | 0.030 |
Why?
|
| Skull Neoplasms | 2 | 1990 | 68 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1979 | 999 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2013 | 337 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2012 | 186 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2011 | 145 | 0.020 |
Why?
|
| Calcaneus | 1 | 1991 | 17 | 0.020 |
Why?
|
| Peer Review | 1 | 1991 | 82 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 1992 | 356 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 709 | 0.020 |
Why?
|
| X Chromosome | 1 | 1992 | 402 | 0.020 |
Why?
|
| Ureteral Obstruction | 1 | 1992 | 146 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2011 | 247 | 0.020 |
Why?
|
| Time Factors | 1 | 2004 | 13006 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2010 | 179 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2011 | 419 | 0.020 |
Why?
|
| Giant Cell Tumors | 2 | 1988 | 33 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2010 | 236 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2011 | 544 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2009 | 89 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 313 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 813 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 1992 | 349 | 0.020 |
Why?
|
| Infant, Newborn | 7 | 1981 | 8699 | 0.020 |
Why?
|
| Graft Survival | 1 | 2012 | 1083 | 0.020 |
Why?
|
| Sternoclavicular Joint | 1 | 2008 | 6 | 0.020 |
Why?
|
| Sheep | 1 | 2009 | 275 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2010 | 9292 | 0.020 |
Why?
|
| Mobile Health Units | 1 | 1988 | 35 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2012 | 847 | 0.020 |
Why?
|
| Arthritis, Reactive | 1 | 1987 | 13 | 0.020 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2009 | 219 | 0.020 |
Why?
|
| Growth Plate | 1 | 1987 | 43 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 1823 | 0.020 |
Why?
|
| Spondylitis, Ankylosing | 1 | 1987 | 38 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2313 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 4000 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 1987 | 606 | 0.020 |
Why?
|
| Arthralgia | 1 | 2008 | 97 | 0.020 |
Why?
|
| Serologic Tests | 1 | 1987 | 147 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1017 | 0.020 |
Why?
|
| Foot | 1 | 1987 | 94 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 1975 | 1485 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1975 | 1435 | 0.020 |
Why?
|
| Technetium Compounds | 1 | 1986 | 12 | 0.020 |
Why?
|
| Physical Examination | 1 | 2008 | 305 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1979 | 2431 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2011 | 823 | 0.020 |
Why?
|
| Neurofibroma | 2 | 1977 | 31 | 0.020 |
Why?
|
| Spinal Neoplasms | 2 | 1988 | 670 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2010 | 1042 | 0.020 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2011 | 530 | 0.020 |
Why?
|
| Osteoclasts | 2 | 1987 | 155 | 0.020 |
Why?
|
| Iohexol | 1 | 2005 | 56 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2012 | 1857 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2005 | 185 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1989 | 527 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 16689 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 4328 | 0.010 |
Why?
|
| Anatomy | 1 | 1983 | 14 | 0.010 |
Why?
|
| Osteoblasts | 2 | 1987 | 393 | 0.010 |
Why?
|
| Adenocarcinoma | 3 | 1982 | 7914 | 0.010 |
Why?
|
| Cadaver | 1 | 1983 | 202 | 0.010 |
Why?
|
| Mediastinal Neoplasms | 2 | 1979 | 427 | 0.010 |
Why?
|
| Acute Disease | 1 | 1987 | 2493 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 707 | 0.010 |
Why?
|
| Bone Matrix | 1 | 1981 | 16 | 0.010 |
Why?
|
| Mass Screening | 1 | 2010 | 1552 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 3046 | 0.010 |
Why?
|
| Aneurysm, Infected | 1 | 1982 | 29 | 0.010 |
Why?
|
| Teaching | 1 | 1983 | 250 | 0.010 |
Why?
|
| Heart Neoplasms | 1 | 2003 | 209 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1987 | 965 | 0.010 |
Why?
|
| Disasters | 1 | 1982 | 107 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1982 | 197 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 5002 | 0.010 |
Why?
|
| Medullary Sponge Kidney | 1 | 1979 | 4 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 9470 | 0.010 |
Why?
|
| Splenic Diseases | 1 | 1980 | 59 | 0.010 |
Why?
|
| Pneumonia | 1 | 1986 | 796 | 0.010 |
Why?
|
| Kidney Medulla | 1 | 1979 | 37 | 0.010 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1979 | 37 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 4963 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 2005 | 862 | 0.010 |
Why?
|
| Meningioma | 1 | 1981 | 308 | 0.010 |
Why?
|
| Texas | 1 | 2009 | 6449 | 0.010 |
Why?
|
| Lymphangiectasis | 1 | 1978 | 8 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 5923 | 0.010 |
Why?
|
| Respiratory Therapy | 1 | 1977 | 30 | 0.010 |
Why?
|
| Recurrence | 1 | 1986 | 4878 | 0.010 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 1977 | 30 | 0.010 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 1977 | 23 | 0.010 |
Why?
|
| Papilloma | 1 | 1977 | 86 | 0.010 |
Why?
|
| Fractures, Bone | 2 | 1991 | 310 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1981 | 473 | 0.010 |
Why?
|
| Lymphangiectasis, Intestinal | 1 | 1976 | 2 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2012 | 4147 | 0.010 |
Why?
|
| Technology, Radiologic | 2 | 1991 | 78 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2005 | 4019 | 0.010 |
Why?
|
| Sex Factors | 1 | 1982 | 2184 | 0.010 |
Why?
|
| Hamartoma | 1 | 1977 | 90 | 0.010 |
Why?
|
| Eye | 1 | 1977 | 283 | 0.010 |
Why?
|
| Leiomyoma | 1 | 1977 | 161 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1976 | 161 | 0.010 |
Why?
|
| Colitis | 1 | 1979 | 341 | 0.010 |
Why?
|
| Neurofibromatosis 1 | 1 | 1977 | 159 | 0.010 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 1975 | 8 | 0.010 |
Why?
|
| Amyloidosis | 1 | 1977 | 173 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1975 | 37 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1975 | 41 | 0.010 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 1975 | 73 | 0.010 |
Why?
|
| Pigmentation Disorders | 1 | 1975 | 42 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1977 | 280 | 0.010 |
Why?
|
| Abnormalities, Multiple | 2 | 1977 | 1023 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 1975 | 113 | 0.010 |
Why?
|
| Endometriosis | 1 | 1977 | 231 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1975 | 220 | 0.010 |
Why?
|
| Ganglioneuroma | 1 | 1973 | 44 | 0.010 |
Why?
|
| Pulmonary Eosinophilia | 1 | 1973 | 14 | 0.010 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 1973 | 35 | 0.010 |
Why?
|
| Lymphoma | 2 | 1988 | 1519 | 0.010 |
Why?
|
| Mucocele | 1 | 1973 | 24 | 0.010 |
Why?
|
| Arteriovenous Fistula | 1 | 1973 | 101 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1976 | 660 | 0.010 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 1991 | 3 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1975 | 344 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1975 | 366 | 0.010 |
Why?
|
| Medicare Part B | 1 | 1991 | 6 | 0.010 |
Why?
|
| Pennsylvania | 1 | 1991 | 68 | 0.010 |
Why?
|
| Bronchi | 1 | 1973 | 325 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1977 | 724 | 0.010 |
Why?
|
| Physicians, Family | 1 | 1991 | 55 | 0.010 |
Why?
|
| Pulmonary Veins | 1 | 1973 | 181 | 0.010 |
Why?
|
| Intestines | 1 | 1976 | 736 | 0.010 |
Why?
|
| Spinal Fusion | 1 | 1992 | 150 | 0.010 |
Why?
|
| Stomach | 1 | 1973 | 402 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1975 | 727 | 0.010 |
Why?
|
| Age Factors | 2 | 1982 | 5457 | 0.010 |
Why?
|
| Osteoma | 1 | 1990 | 9 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1973 | 278 | 0.010 |
Why?
|
| Body Weight | 1 | 1975 | 1307 | 0.010 |
Why?
|
| Airway Obstruction | 1 | 1973 | 273 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1973 | 718 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 14617 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 1990 | 143 | 0.010 |
Why?
|
| Joint Dislocations | 1 | 1989 | 34 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1973 | 521 | 0.010 |
Why?
|
| Anemia | 1 | 1975 | 728 | 0.010 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 1988 | 12 | 0.000 |
Why?
|
| Osteoma, Osteoid | 1 | 1988 | 24 | 0.000 |
Why?
|
| Adenoma | 1 | 1973 | 740 | 0.000 |
Why?
|
| Epiphyses, Slipped | 1 | 1987 | 6 | 0.000 |
Why?
|
| Salter-Harris Fractures | 1 | 1987 | 7 | 0.000 |
Why?
|
| Bone Diseases, Developmental | 1 | 1987 | 70 | 0.000 |
Why?
|
| Bone Diseases, Metabolic | 1 | 1987 | 81 | 0.000 |
Why?
|
| Endocrine System Diseases | 1 | 1987 | 89 | 0.000 |
Why?
|
| Animals | 2 | 2009 | 61956 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1991 | 518 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1977 | 3077 | 0.000 |
Why?
|
| Epithelium | 2 | 1980 | 782 | 0.000 |
Why?
|
| Muscular Diseases | 1 | 1987 | 161 | 0.000 |
Why?
|
| Hematologic Diseases | 1 | 1987 | 255 | 0.000 |
Why?
|
| Technetium | 1 | 1986 | 79 | 0.000 |
Why?
|
| Phosphates | 1 | 1986 | 178 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1987 | 235 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1987 | 683 | 0.000 |
Why?
|
| Pregnancy | 1 | 1977 | 8130 | 0.000 |
Why?
|
| Brain | 1 | 1977 | 4208 | 0.000 |
Why?
|
| Minerals | 1 | 1981 | 72 | 0.000 |
Why?
|
| Bone Resorption | 1 | 1982 | 137 | 0.000 |
Why?
|
| Craniocerebral Trauma | 1 | 1981 | 154 | 0.000 |
Why?
|
| Echinococcosis | 1 | 1980 | 14 | 0.000 |
Why?
|
| Osteogenesis | 1 | 1982 | 272 | 0.000 |
Why?
|
| Amebiasis | 1 | 1979 | 14 | 0.000 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 1979 | 13 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1981 | 418 | 0.000 |
Why?
|
| Education, Medical | 1 | 1983 | 344 | 0.000 |
Why?
|
| Ulcer | 1 | 1979 | 79 | 0.000 |
Why?
|
| Spleen | 1 | 1980 | 726 | 0.000 |
Why?
|
| Granuloma | 1 | 1979 | 153 | 0.000 |
Why?
|
| Colitis, Ulcerative | 1 | 1979 | 258 | 0.000 |
Why?
|
| Colon | 1 | 1979 | 659 | 0.000 |
Why?
|
| Mice | 1 | 1987 | 35600 | 0.000 |
Why?
|